| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/04/2001 | WO2001000848A1 Useful polypeptide |
| 01/04/2001 | WO2001000847A1 Dihydroorotate dehydrogenase sequence of corynebacterium glutamicum and the use thereof in microbial production of pyrimidine and/or compounds used with pyrimidine |
| 01/04/2001 | WO2001000846A2 Linoleate isomerase |
| 01/04/2001 | WO2001000845A1 Genes from corynebacterium glutamicum for the biosynthesis of folic acid and their use for the microbial production of folic acid |
| 01/04/2001 | WO2001000844A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 01/04/2001 | WO2001000843A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2001 | WO2001000842A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 01/04/2001 | WO2001000841A1 Insecticidal proteins from paecilomyces and synergistic combinations thereof |
| 01/04/2001 | WO2001000840A1 Insecticidal and nematicidal proteins |
| 01/04/2001 | WO2001000839A1 Tetanus toxin polypeptides |
| 01/04/2001 | WO2001000838A1 Cloning of basb110 antigen from moraxella (branhamella) catarrhalis |
| 01/04/2001 | WO2001000837A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 01/04/2001 | WO2001000836A1 Novel compounds |
| 01/04/2001 | WO2001000835A1 Moraxella catarrhalis polypeptides |
| 01/04/2001 | WO2001000834A1 Gene affecting male fertility in plants |
| 01/04/2001 | WO2001000833A1 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained |
| 01/04/2001 | WO2001000832A1 Methods for making apo-2 ligand using divalent metal ions |
| 01/04/2001 | WO2001000831A1 Helical polypeptide zalpha29 |
| 01/04/2001 | WO2001000830A1 Sgip peptides |
| 01/04/2001 | WO2001000829A2 Human endogenous retrovirus in breast cancer |
| 01/04/2001 | WO2001000828A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/04/2001 | WO2001000827A1 Apaf-1 compositions and methods to identify apoptosis signalling pathway modulators |
| 01/04/2001 | WO2001000826A2 Novel molecules of the card-related protein family and uses thereof |
| 01/04/2001 | WO2001000825A2 Human chromosome 15 and 16 bardet-biedl syndrome polynucleotides and polypeptides and methods of use |
| 01/04/2001 | WO2001000824A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/04/2001 | WO2001000823A1 NOVEL ISOFORMS OF THE HUMAN ESTROGEN RECEPTOR-$g(a) |
| 01/04/2001 | WO2001000822A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 01/04/2001 | WO2001000821A1 Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof |
| 01/04/2001 | WO2001000820A2 METHODS AND COMPOSITIONS FOR PRODUCING 5' ENRICHED cDNA LIBRARIES |
| 01/04/2001 | WO2001000819A1 Targeted gene replacements in enteric bacteria using linear dna |
| 01/04/2001 | WO2001000817A1 Compositions and methods for determining the activity of dna-binding proteins and of initiation of transcription |
| 01/04/2001 | WO2001000816A1 Methods of cloning and producing fragment chains with readable information content |
| 01/04/2001 | WO2001000815A1 Molecular switches |
| 01/04/2001 | WO2001000814A2 Hetero-associating coiled-coil peptides and screenign method therefor |
| 01/04/2001 | WO2001000813A1 Method for eliminating nucleic acid amplification inhibitors |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000811A2 17867, a novel human aminopeptidase |
| 01/04/2001 | WO2001000809A1 Self-induced deletion of dna |
| 01/04/2001 | WO2001000808A1 Antisense modulation of ship-2 expression |
| 01/04/2001 | WO2001000806A2 Dna's encoding proteins with signal peptides |
| 01/04/2001 | WO2001000805A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 01/04/2001 | WO2001000804A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 01/04/2001 | WO2001000803A2 Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof |
| 01/04/2001 | WO2001000802A2 Partial sequences of the genes of the primary and secondary metabolism from corynebacterium glutamicum |
| 01/04/2001 | WO2001000801A2 Gene involved in epigenetic gene silencing |
| 01/04/2001 | WO2001000799A1 Novel protein and dna thereof |
| 01/04/2001 | WO2001000797A1 Sulfur atom-free enzyme proteins |
| 01/04/2001 | WO2001000795A1 A method for producing cloned cows |
| 01/04/2001 | WO2001000794A1 Method for producing cloned tigers by employing inter-species nuclear transplantation technique |
| 01/04/2001 | WO2001000793A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique |
| 01/04/2001 | WO2001000790A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 01/04/2001 | WO2001000786A2 Bacteriophage library useful for typing bacteria and system and method utilizing same |
| 01/04/2001 | WO2001000785A2 Regeneration of cotton plants |
| 01/04/2001 | WO2001000784A2 Compound derived from an offset orf of the ice gene |
| 01/04/2001 | WO2001000709A1 Copolymers for the transfer of nucleic acids to the cell |
| 01/04/2001 | WO2001000708A1 Combinations for introducing nucleic acids into cells |
| 01/04/2001 | WO2001000669A2 A bap28 gene and protein |
| 01/04/2001 | WO2001000668A1 Extraction of integral membrane proteins |
| 01/04/2001 | WO2001000666A2 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 01/04/2001 | WO2001000665A2 Inhibitors of memapsin 2 and use thereof |
| 01/04/2001 | WO2001000663A2 Catalytically active recombinant memapsin and methods of use thereof |
| 01/04/2001 | WO2001000661A2 Carnitine carrier related protein-1 |
| 01/04/2001 | WO2001000651A1 ANTISENSE MODULATION OF G-ALPHA-i3 EXPRESSION |
| 01/04/2001 | WO2001000650A1 Cytoplasmic transfer to de-differentiate recipient cells |
| 01/04/2001 | WO2001000649A1 FtsA |
| 01/04/2001 | WO2001000648A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | WO2001000647A1 Antisense modulation of ets-2 expression |
| 01/04/2001 | WO2001000646A1 Antisense modulation of jun n-terminal kinase kinase-2 expression |
| 01/04/2001 | WO2001000645A1 Antisense modulation of integrin beta 3 expression |
| 01/04/2001 | WO2001000643A2 Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase |
| 01/04/2001 | WO2001000642A1 High affinity, low molecular weight displacers for oligonucleotide purification |
| 01/04/2001 | WO2001000244A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
| 01/04/2001 | WO2001000237A1 Synthetic peptide immunogens and antibodies thereto |
| 01/04/2001 | WO2001000235A1 Prion protein binding proteins and uses thereof |
| 01/04/2001 | WO2001000234A2 Methods and compositions for engineering of attenuated vaccines |
| 01/04/2001 | WO2001000220A2 Lipoprotein lipase (lpl) variant therapeutics |
| 01/04/2001 | WO2001000015A1 Goodpasture's syndrome model mouse |
| 01/04/2001 | WO2001000014A2 Test animal for atherosclerosis model and methods for testing and screening |
| 01/04/2001 | WO2000064400A3 Methods for treating congestive heart failure |
| 01/04/2001 | WO2000061611A3 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/04/2001 | WO2000060082A3 Vesicle associated proteins |
| 01/04/2001 | WO2000058501A3 Novel genetic suppressor elements and methods of making the same |
| 01/04/2001 | WO2000058481A3 Phosphatases with improved phytase activity |
| 01/04/2001 | WO2000058457A3 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs |
| 01/04/2001 | WO2000058455A3 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
| 01/04/2001 | WO2000057921A3 Peroral gene therapy of diabetes and obesity |
| 01/04/2001 | WO2000057909A3 Attenuated dengue-2 virus vaccine |
| 01/04/2001 | WO2000056405A3 Human tumor necrosis factor receptor-like 2 |
| 01/04/2001 | WO2000056358A3 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 01/04/2001 | WO2000055327A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 01/04/2001 | WO2000053788A3 Compositions and methods for recombinant adeno-associated virus production |
| 01/04/2001 | WO2000052162A3 Eukaryotic peptide uptake system for transportation of enkephalins |
| 01/04/2001 | WO2000052145A3 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 01/04/2001 | WO2000050629A3 Diagnostic and screening method for male infertility |
| 01/04/2001 | WO2000050601A3 Nucleic acid and amino acid sequences of hemoglobin-response genes in candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated candida albicans infection |
| 01/04/2001 | WO2000049145A3 Hematopoietic genes hzf and hhl and polypeptides encoded thereof |
| 01/04/2001 | WO2000040755A3 Method for accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing |
| 01/04/2001 | WO2000039302A3 Improved expression of hiv polypeptides and production of virus-like particles |
| 01/04/2001 | WO2000037060A3 Transgenic plants comprising a conditionally lethal gene |
| 01/04/2001 | WO2000029617A9 Water-soluble luminescent quantum dots and bioconjugates thereof |